HDAC2 and colorectal cancer: Growth inhibition and apoptosis were observed in PA‐treated HCT116 and SW480 colorectal cancer cells, induced by a decrease in histone deacetylase 2 (HDAC2) expression and HDAC enzyme activity, and subsequent repression of c‐Myc and activation of the NF‐κB pathway.25